Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss Bioventus BVS Q1 2026 Earnings Strong EPS Beat Amidst Market Skepticism WPM Q1 2026 Earnings EPS Beats Expectations on Strong Precious Metals Performance DVS Q4 2025 Earnings WiderthanExpected Loss Reflects Exploration Focus GLIBK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Drops GTES Q1 2026 Earnings EPS Beats Estimates by 47 Shares Edge Higher